Medical Care / Hormone Refractory Prostate Cancer Market - Global Growth, Trends And Forecast (2022 - 2027) By Types, By Application, By Regions And By Key Players: Astellas Inc, Sanofi S.A, Dendreon Corporation, Bayer AG
Hormone Refractory Prostate Cancer Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Astellas Inc, Sanofi S.A, Dendreon Corporation, Bayer AG
Acknowledging the kind of traction gained by this market, recently published a study report asserts the global Hormone Refractory Prostate Cancer Market size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of 8.1% during the review period (2022 to 2027).
Hormone Refractory Prostate Cancer Market Overview
Hormone refractory prostate cancer (HRPC) is also known as Castrate-Resistant Prostate Cancer (CRPC). It is an irregular type of cancer that relapses even after hormonal therapy. Nowadays it has been categorized under prostate cancer.
Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC) is a type of prostate cancer that recurs after hormonal therapy. Due to the high unmet clinical need associated with limited survival periods, intensifying HRPCA prevalence, and fast-emerging treatment modifications, the global HRPCA market is poised to witness unprecedented growth.
The report aspects discussed the profile of the top manufacturers of the global Hormone Refractory Prostate Cancer market. These aspects include the financial status of major companies, trending advancements, and the entire market scenario. Growth of the report has examined the Hormone Refractory Prostate Cancer Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.
Who are the Major Players in Hormone Refractory Prostate Cancer Market?
The global Hormone Refractory Prostate Cancer includes the identification and analysis of the various market participants competing in the global market. Prominent competitors include Astellas Inc, Sanofi S.A, Dendreon Corporation, Bayer AG, Johnson & Johnson, and Others.
Industry News:
Real-World Evidence Shows Adding PROVENGE (sipuleucel-T) to Advanced Prostate Cancer Treatment Regimen Prolonged Median Survival by 14.5 Months
October 14, 2020 - SEAL BEACH, Calif. -- Dendreon Pharmaceuticals, a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy, today announced the publication of an analysis examining real-world survival outcomes in men with metastatic castrate-resistant prostate cancer (mCRPC) who were treated with PROVENGE (sipuleucel-T) and commonly prescribed oral treatments.
What are the major Applications, Types, and Regions of the Hormone Refractory Prostate Cancer Market?
By Type, it is segmented into
Chemotherapy
Hormonal Therapy
Immunotherapy
Radiation Therapy
By Application,it is segmented into
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Hormone Refractory Prostate Cancer Market Regional Analysis
The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. North America is accounting for the largest market value of USD 2.38 Billion in 2020, owing to the highly developed treatment scenarios in this region. Europe is expected to hold the second-largest market share in the global Hormone Refractory Prostate Cancer market. Followed by Europe the other regions like the Asia Pacific, MEA, and Latin America which have a large pool of undiagnosed Hormone Refractory Prostate Cancer would continue to grow with increasing awareness and advanced screening technology.
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World
Middle East & Africa
Latin America
The world's most powerful economies The most crucial regions for this market would be India and China. As the rate of education rises in emerging nations, more people are becoming aware of the various types of cancer and the treatment options available. This market has a lot of untapped potentials.
What is our Hormone Refractory Prostate Cancer Market report scope?
Report Attributes
Report Details
Report Title
Hormone Refractory Prostate Cancer Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions, and By Key Players: Astellas Inc, Sanofi S.A, Dendreon Corporation, Bayer AG, Johnson & Johnson
Forecast Period 2022 to 2027 CAGR
CAGR of 8.1 % over the forecast period (2022-2027)
By Type
Chemotherapy
Hormonal Therapy
Immunotherapy
Radiation Therapy
Others
By Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
By Companies
Astellas Pharma Inc. (Tokyo:4503.T),Sanofi S.A. (Stuttgart:SNW.SG), Dendreon Corporation, Bayer Aktiengesellschaft (XETRA :BAYN.DE),Johnson & Johnson (NYSE:JNJ)
Regions Covered
North America
Europe
Asia-Pacific
Rest of the World
Countries Covered
US
Canada
Germany
France
UK
Italy
Spain
Rest of Europe
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
Latin America
Base Year
2022
Historical Year
2017 to 2021
Forecast Year
2022 to 2027
Number of Pages
81
Customization Available
Yes, the report can be customized as per your needs
Key Takeaways from this Hormone Refractory Prostate Cancer Report
Evaluate Hormone Refractory Prostate Cancer market potential by analyzing growth rates (CAGR %), Volume (Units), and Value ($M) data given at the country level - for product types, end-use applications, and by different industries verticals.
Understand the different dynamics influencing the market - growth driving factors, specific challenges, and hidden opportunities.
Get in-depth insights on your competitor's performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis, and more.
Analyze the sales and distribution channels across geographies to enhance top-line revenues.
Understand the demanding supply chain with a deep dive into the value augmentation at each, to optimize value and bring efficiencies to your processes.
Get a quick outlook on the Hormone Refractory Prostate Cancer market entropy - M&As, deals, partnerships, and product launches of all key players for the past 4 years.
Evaluate the import-export statistics, supply-demand, and competitive landscape for more than the top 20 countries globally for the market.
All our reports are custom made to your company's needs to a certain extent, we do provide 5 free consulting hours along with the purchase of each report, and this will allow you to request any additional data to customize the report to your needs.
Frequently Asked Questions
How do you conduct primary research interviews?
We use tools such as video conferences, telephone calls, face-to-face interviews, and questionnaires with key respondents.
What if the report I want is not listed in the repository of your reports?
Market Insights Reports has a repository of reports on various industry verticals and not all of them have been listed on the website. Please contact our sales team with your requirements.
Who are the key players in Hormone Refractory Prostate Cancer Market?
Astellas Inc, Sanofi S.A, Dendreon Corporation, Bayer AG, Johnson & Johnson
What regions does this Hormone Refractory Prostate Cancer Market report cover?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of Hormone Refractory Prostate Cancer Market?
SECONDARY RESEARCH Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
